Between Science and Spirit: Rethinking Mental Health with Psychedelic Therapy

Isabella Mendoza, Alma Razavillar, Aneesa Mustafa, Sania Choudhary

Study at a glance

Characteristics	Interview Peer reviewed
Topics	Addiction Psychedelic-assisted therapy
Keywords	Mental health Mental disease Psychological therapy Psychotherapist

Interview with Dr. Brian Anderson

Other qualitative studies on psychedelic-assisted therapy, most cited first.

Study	Year	Design	Participants
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression enrolled in an open-label trial of psilocybin	2017	Qualitative study	n = 20
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Patients with anxiety associated with life-threatening diseases	2014	Prospective follow-up with qualitative content analysis	n = 10
Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Adults aged 22 to 69 with clinically elevated anxiety associated with a cancer diagnosis	2017	Qualitative study	n = 13
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts Participants who completed a psilocybin-facilitated smoking cessation pilot study	2018	Qualitative follow-up study using semi-structured interviews and thematic analysis	n = 12
The hidden therapist: evidence for a central role of music in psychedelic therapy Patients undergoing psychedelic therapy with psilocybin for treatment-resistant depression	2018	Qualitative study	n = 19